Trending

U.S. FDA enlists Clearbridge Biomedic’s ClearCell FX1 system

Read more

GT Biopharma completes dosing in Phase 1 Clinical Trial for GTP-004 to treat Myasthenia Gravis

Read more

Wuxi NextCode partners with Rhythm to treat rare Obesity Genetic Disorders

Read more

Emotional Brain declares successful Phase 2B trials for FSIAD products Lybrido and Lybridos

Read more

Aerin to rollout VIVAER for overcoming nasal airway obstruction

Read more

ESN Group Rolls out Ceramedx, a brand of natural ceramide therapy products

Read more

Aimmune plans to declare results of Phase 3 PALISADE Trial of AR101 for Peanut Allergy

Read more

Guangdong Lewwin Pharmaceutical purchases Provantis Preclinical software solution suite

Read more

Neil Herson appointed Senior VP of National Accounts and Market Access of Octapharma USA

Read more

Kala Pharma application for new drug INVELTYSTM set to be evaluated by FDA

Read more